¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"heparin therapy monitoring"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • radiation therapy
    ¹æ»ç¼±¿ä¹ý
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • rational-emotive therapy
    À̼º°¨¼º¿ä¹ý
  • reality therapy
    Çö½Ç¿ä¹ý
  • replacement therapy
    º¸»ó¿ä¹ý
  • self-control therapy
    ÀÚ±âÁ¶Àý¿ä¹ý
  • spiritual therapy
    ¿µÀû¿ä¹ý
  • supportive therapy
    ÁöÁö¿ä¹ý
  • symptomatic therapy
    ´ëÁõ¿ä¹ý
  • systemic therapy
    Àü½Å¿ä¹ý
  • therapy
    ¿ä¹ý
  • thrombolytic therapy
    Ç÷Àü¿ëÇØ¿ä¹ý
  • topical therapy
    ±¹¼Ò¿ä¹ý
  • ultrasonic therapy
    (¢¡ultrasound therapy) ÃÊÀ½ÆÄ¿ä¹ý
  • ultrasound therapy
    ÃÊÀ½ÆÄ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • relaxation therapy
    À̿Ͽä¹ý
  • remission induction therapy
    °üÇØÀ¯µµÄ¡·á(ΰú°ë¯Óôö½èþ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • directive group therapy
    Áö½Ã¼º Áý´Ü¿ä¹ý
  • drug therapy
    ¾à¹° ¾à¹°¿ä¹ý(¡­èþÛö).
  • dual-sex therapy
    ÀÌÁß ¼º(àõ)¿ä¹ý
  • duplex therapy
    ÀÌÁß¿ä¹ý(ì£ñìèþÛö).
  • educational therapy
    ±³À°¿ä¹ý
  • electoconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý.
  • electric shock therapy(EST)
    Àü±âÃæ°Ý¿ä¹ý.
  • electroconvulsion therapy
    Àü±â°æ·Ã¿ä¹ý
  • electroconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý.
  • electroconvulsive therapy(ECT)
    Àü±â°æ·Ã¿ä¹ý.
  • electron beam therapy
    ÀüÀÚ¼±Ä¡·á
  • electron beam therapy
    ÀüÀÚ¼±Ä¡·á(¡­ö½èþ).
  • electron-beam therapy
    ÀüÀÚ¼± Ä¡·á
  • evocative group therapy
    Ç¥ÇöÀû Áý´Ü¿ä¹ý(øúúÞîÜó¢Ó¥ÖûÛö)
  • exposure therapy
    ³ëÃâ¿ä¹ý(ÒËõóÖûÛö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
HIT hemagglutination inhibition test; heparin-induced thrombocytopenia; histamine inhalation test; hyper...
HITT heparin-induced thrombocytopenia and thrombosis
HITTS heparin-induced thrombosis-thrombocytopenia syndrome
HL hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph...
HNA heparin neutralizing activity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
HEP 1--heparin
HSPG heparin sulfate proteoglycan
H Heparin
HE Heparin
HBGF Heparin binding growth factors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ¥ã-ray therapy
    °¨¸¶¼± ¿ä¹ý
    °¨¸¶¼±À» ÀÌ¿ëÇÏ¿© Á¾¾ç°ú °°Àº °ÍÀ» Ä¡·áÇÏ´Â ¹æ¹ý. °¨¸¶¼±Àº õ¿¬ÀÇ ¹æ»ç´É¹°Áú ¶Ç´Â ÀΰøÀûÀ¸·Î ¸¸µé¾îÁø ¹æ»ç¼º µ¿À§¿ø¼ÒÀÇ ¿øÀÚÇÙ¿¡¼­ ¹æ»çµÇ´Âµ¥, õ¿¬ÀÇ ¹æ»ç´É¹°ÁúÀº ´ëü·Î ¼±¿øÀ¸·Î¼­ÀÇ ¼±·®ÀÌ Àû±â ¶§¹®¿¡, ¶óµã ħ, ¶óµã°ü, ¶óµ·Ä§°ú °°Àº À̸¥¹Ù ¼Ò¼±¿øÀ» Á¾¾çÁ¶Á÷ ³»¿¡ Âñ·¯ ³Ö°Å³ª Á¾¾çÀÇ Ç¥¸é¿¡ ³ª¶õÈ÷ ºÙÀÌ´Â Ä¡·á¹ýÀ» ¸¹ÀÌ »ç¿ëÇÑ´Ù. ÀΰøÀûÀÎ ¹æ»ç¼º µ¿À§¿ø¼Ò´Â °í¹ßÆ® ħ°ú °°ÀÌ 10 mCi Á¤µµ±îÁöÀÇ ¼Ò¼±¿øÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ°í, ¼öõ Ci¶ó´Â ´ë¼±¿øÀ¸·Î ¿ø°ÝÁ¶»ç¹ýÀ» ½Ç½ÃÇÒ ¼öµµ ÀÖ´Ù. ÄÚ¹ßÆ® 60¿¡¼­ ¹æ»çµÇ´Â ¥ã¼±ÀÇ ¿¡³ÊÁö´Â ´ëü·Î 3,000 kVÀÇ X¼±°ú °°´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
combined modality therapy <oncology> Two or more types of treatments used to supplement each other.
For instance, surgery, radiation, chemotherapy, hormonal or immunotherapy may be used alternatively or together for maximum effectiveness.
(09 Oct 1997)
motion therapy, continuous passive Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.
(12 Dec 1998)
plasma therapy Treatment with plasma.
(05 Mar 2000)
mud therapy The therapeutic use of mud in packs or baths. It includes mud, earth, clay, and peat. The original mud was fango, a volcanic mud from the battaglia thermal springs in italy, applied externally in the treatment of rheumatism and other diseases of the joints and muscles.
(12 Dec 1998)
play therapy A treatment technique utilizing play as a medium for expression and communication between patient and therapist.
(12 Dec 1998)
conditioning therapy The application of modern theories of learning and conditioning in the treatment of behaviour disorders.
(12 Dec 1998)
conjoint therapy A type of therapy in which a therapist sees the two spouses, or parent and child, or other partners together in joint sessions.
(05 Mar 2000)
convulsive therapy The use of convulsive agents to influence favourably the course of a mental disorder. It is used primarily in the treatment of severe affective disorders and schizophrenia.
(12 Dec 1998)
music therapy <psychiatry> A form of distraction that uses music as an aid to relaxation.
(16 Dec 1997)
myofunctional therapy Therapy of malocclusion and other dental and speech disorders utilizing muscular exercises of the tongue and lips; most often intended to alter a tongue thrust swallowing pattern.
(05 Mar 2000)
couples therapy Psychotherapy used specifically for unmarried couples, of mixed or same sex.
(12 Dec 1998)
postremission therapy Chemotherapy to kill leukaemia cells that survive after remission induction therapy.
(12 Dec 1998)
cytoreductive therapy Therapy with the intention of reducing the number of cells in a lesion, usually a malignancy.
(05 Mar 2000)
salvage therapy <oncology> The final possible treatment for people who are nonresponsive to or cannot tolerate other available treatments for a particular condition.
(14 Oct 1997)
proliferation therapy Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á